Emerging markets series: Benchmarking key countries Brazil, Russia, India, China and Turkey

Declining growth rates in developed markets mean many pharmaceutical companies are turning their attention to developing markets. Economic growth and healthcare reforms means many non-traditional markets are experiencing tremendous growth. This report from Datamonitor provides insight into the key macroeconomic and healthcare trends that are impacting markets in Brazil, Russia, India, China and Turkey. Whilst non of these markets provide the ideal market for Western businesses, their increasing transition towards a more westernized model means that they offer much potential.
Gain insight into the opportunities available for international companies in these markets and assess the challenges that they must overcome in order to succeed.